Modi's generics-only drugs plan worries health experts, Indian pharma sector

MUMBAI (Reuters) – India’s plan to bring in a law to ensure doctors prescribe medicines only by their generic names risks proliferating the sale of substandard drugs in a country where regulation is already lax, doctors and pharmaceutical executives say.

Source: Reuters Health News